# BICARA THERAPEUTICS INC (BCAX)

> Institutional ownership reported to the SEC as of Q3 2026, from Form 13F filings. Source: https://holderbook.com/stocks/BCAX/

- Reporting holders: 4
- Reported value: $37.9K
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [GAMMA Investing LLC](https://holderbook.com/funds/2010235-gamma-investing-llc/) | $27.7K | 1,491 | 0.0% | 8 |
| [Versant Capital Management, Inc](https://holderbook.com/funds/1735057-versant-capital-management-inc/) | $8.1K | 434 | 0.0% | 6 |
| [Farther Finance Advisors, LLC](https://holderbook.com/funds/1992825-farther-finance-advisors-llc/) | $1.5K | 82 | 0.0% | 5 |
| [CoreCap Advisors, LLC](https://holderbook.com/funds/1902501-corecap-advisors-llc/) | $596 | 32 | 0.0% | 5 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q3 2026 | 4 | $37.9K |
| Q2 2026 | 178 | $2.3B |
| Q1 2026 | 148 | $1.4B |
| Q4 2025 | 141 | $1.0B |
| Q3 2025 | 116 | $790.5M |
| Q2 2025 | 108 | $475.4M |
| Q1 2025 | 93 | $633.9M |
| Q4 2024 | 85 | $813.6M |
| Q3 2024 | 69 | $927.6M |